Atossa Genetics Announces Completion of Enrollment and Dosing in Phase 1 Clinical Trial of New Proprietary Modified-Release Oral Endoxifen Tablet

September 3, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search